Upgrade to SI Premium - Free Trial

Clover Health Investments (CLOV) reports Q4 results; offers guidance

March 12, 2024 4:16 PM

Clover Health Investments (NASDAQ: CLOV) reported Q4 Revenue for the quarter at $510.3 million versus the consensus estimate of $474.01 million.

GUIDANCE:

Clover Health Investments sees FY2024 Insurance revenue of $1.25-1.3 billion. Insurance MCR of 79% - 83%. Adjusted EBITDA (Non-GAAP) of ($20) million - $20 million

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

Categories

Earnings Guidance